摘要
目的:观察清肺消炎丸对慢性肺源性心脏病患者急性发作期(痰热壅肺证)疗效和免疫功能的影响。方法:将80例患者随机单盲分为两组,对照组40例采用西医常规治疗,治疗组40例则在对照组基础上,加用清肺消炎丸,观察两组治疗前后疗效、免疫球蛋白和T细胞亚群的变化。结果:对照组和治疗组治疗后与治疗前分别比较有显著差异(P<0.05),两组治疗后免疫球蛋白及T细胞亚群比较,治疗组与对照组比较也有明显差异(P<0.05),从而说明清肺消炎丸能提高肺心病患者的免疫功能。结论:清肺消炎丸对肺心病患者有增强患者细胞免疫功能的作用,并且不良反应小。
Objective : To observe the curative effect and immune function of Lung - clearing and Anti - inflammatory ( Qingfei Xiaoyan) Pills in the treatment of chronic pulmonary heart disease ( Syndrome of Phlegm - heat Obstructing Lung) at the acute stage. Methods:Eighty patients were divided into two groups in random single blind trial. The conventional western medicine treat- ment were given to 40 cases in control group and 40 cases in treatment group. On this basis, the latter took Lung - clearing and Anti - inflammatory ( Qingfei Xiaoyan) Pills. The changes of immunoglobulin and T cell subset before and after the treatment were observed and recorded. Results : Compared with curative effect before treatment, there were significant differences ( P 〈 0. 05 ) in control group and treatment group after treatment. Compared with control group, there were also significant differences ( P 〈 0. 05 ) in immunoglobulin and T cell subset of treatment group. Therefore, it is indicated that Lung - clearing and Anti - inflammatory (Qingfei Xiaoyan) Pills can improve the immune function of patients with pulmonary heart disease. Conclusion:Lung -clearing and Anti - inflammatory ( Qingfei Xiaoyan) Pills can strengthen the cellular immune function of patients suffered pulmonary heart disease with less toxic side - effects.
出处
《辽宁中医杂志》
CAS
北大核心
2016年第9期1892-1894,共3页
Liaoning Journal of Traditional Chinese Medicine
基金
天津市中医药管理局的课题(13054)
关键词
清肺消炎丸
肺心病
免疫
Lung - clearing and Anti - inflammatory ( Qinjei Xiaoyan) Pills
pulmonary heart disease
immune